Faheem Hasnain, EVP, Oncology/Rheumatology SBU at BIOGEN IDEC INC. (BIIB), sold 36,837 shares at $61.71 ($2.3M) on 2008-07-09, disclosed to the SEC on 2008-07-10.
Scheduled sale ($2.3M) by EVP, Oncology/Rheumatology SBU under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.71 | 21,037 | $1.3M | 56.8% |
| 2 | $62.56 | 15,800 | $988K | 43.2% |
| Total | $62.07 avg | 36,837 | $2.3M | 100% |
| Filing → |
| GOSS | BUY | 2024-06-24 | $498K | — | Filing → |
| GOSS | SELL | 2024-03-28 | $27K | — | Filing → |
| MRTX | BUY | 2023-08-14 | $600K | — | Filing → |